Clinical Trials · NCT01969149
Exenatide for Stress Hyperglycemia
- Phase
- Phase 2/Phase 3
- Recruitment status
- Completed
- Sponsor
- Centre Hospitalier Universitaire de Besancon
- Enrollment
- 110
- Start date
- Jan 2015
- Locations
- 1 site, France
- Primary endpoint
- Percentage of patients spending more than 50 % of the time in the glycemic target range (100 to 140 mg/dl)